- Home
- GTBP vs TWAV Comparison
GTBP vs TWAV Comparison
Compare GTBP & TWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.46
N/A
Current Price
$0.69
Company Overview
Basic Information| Metric | GTBP | TWAV |
|---|---|---|
| Founded | 1965 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 7.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GTBP | TWAV |
|---|---|---|
| Price | $0.46 | $0.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 66.0K |
| Earning Date | 03-27-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,378,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.40 | $0.61 |
| 52 Week High | $3.85 | $5.50 |
Technical Indicators
Market Signals| Indicator | GTBP | TWAV |
|---|---|---|
| Relative Strength Index (RSI) | 33.64 | 16.79 |
| Support Level | $0.44 | $0.96 |
| Resistance Level | $0.53 | $1.25 |
| Average True Range (ATR) | 0.06 | 0.24 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 18.44 | 6.55 |
Price Performance
Historical Comparison GTBP
TWAV
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.